InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Countouriotis Athena, Chief Executive Officer. Officer active across 1 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 2 reports have been logged. Total volume traded: €189k. The latest transaction was filed on 9 February 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€94,4272,971 shares@ €31.7828100.0% of flow
Common Stock
SEC:0001209191-22-008979·
€94,4272,971 shares@ €31.782850.0% of flow
Common Stock
SEC:0001209191-22-008979:0·
2 of 2 declarations
About Countouriotis Athena
Athena Countouriotis is the President and CEO at Turning Point Therapeutics, Inc. She is responsible for the strategic direction and management of the company's operations. Athena plays a vital role in developing growth initiatives and enhancing customer experience. Her leadership and strategic vision are crucial for Turning Point's success.
